UBS O'Connor’s Endo International plc ENDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-275,000
Closed -$358K – 1033
2020
Q4
$358K Sell
275,000
-200,000
-42% -$1.04M 0.01% 521
2020
Q3
$238K Buy
+475,000
New +$1.52M 0.01% 278
2020
Q1
– Sell
-100,000
Closed -$2K – 416
2019
Q4
$2K Sell
100,000
-1,000,000
-91% -$4.46M ﹤0.01% 315
2019
Q3
$112K Hold
1,100,000
– – ﹤0.01% 282
2019
Q2
$260K Buy
1,100,000
+1,000,000
+1,000% +$6.31M 0.01% 208
2019
Q1
$35K Buy
+100,000
New +$940K ﹤0.01% 227

Other funds holding ENDP

UBS O'Connor's ENDP Position: Q2 2021 in Review

UBS O'Connor sold out of Endo International plc (ENDP) in Q2 2021, closing a stake of 64,474 shares — an estimated $370K sold.

UBS O'Connor first reported a position in ENDP in Q2 2019 and held it in 8 quarters. The position peaked at $1.97M in Q4 2019. 203 funds tracked by Wall St. Rank hold ENDP as of Q2 2021.

  • UBS O'Connor reported no remaining Endo International plc position as of Q2 2021 after selling out during the quarter.
  • UBS O'Connor sold 64,474 Endo International plc shares in Q2 2021, an estimated $370K.
  • UBS O'Connor first reported a position in Endo International plc in Q2 2019 and held it in 8 quarters.
  • UBS O'Connor's Endo International plc position peaked at $1.97M in Q4 2019.
  • 203 funds tracked by Wall St. Rank held Endo International plc as of Q2 2021.

Based on UBS O'Connor's 13F filing for Q2 2021, filed 13 Aug 2021.